Global Blood Testing Market, By Test Type (Glucose, A1C, Direct LDL, Lipid panel, Prostate-specific antigen, COVID-19, BUN testing, Vitamin D, Thyroid-stimulating hormone, Serum Nicotine / Cotinine, High sensitivity CRP, Testosterone, ALT, Cortisol, Creatinine, AST, Other tests) and opportunities and forecast 2020-2027
Blood Testing Market Overview
Blood tests are a standard part of routine and preventive healthcare. A doctor will often order a blood test before or following a physical examination. A doctor may also order blood tests to evaluate specific conditions. Increasing importance and demand for blood testing are anticipated to boost the growth of the global blood testing market in the forthcoming years.
The growth of the global blood testing market is expected to enlarge by increasing the level of awareness amongst patients about various self-testing and home diagnostic tests. As well, patients suffering from diseases like diabetes are anticipated to contribute remarkably toward the development of the global blood testing market. Furthermore, healthcare practitioners have become increasingly dependent on diagnostic care, which is driven by several medical and diagnostic tools. It offers comparable testing accuracy of laboratory tests and reduced turnaround time. This key fact is projected to rise the demand for blood testing, which in turn fuels the growth of the market.
Moreover, growing medical spending by the government and regulatory bodies is projected to drive the market during the forecast period. Government and key organizations are constantly engaged in encouraging patients to undergo regular diagnostic examinations.
Covid-19 Impact on Blood Testing Market
In addition, the current Blood Testing Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Blood Testing Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
Blood Testing Market Segment Overview
According to test type, the Glucose segment accounted for the largest revenue share of the global blood testing market in 2020. This can be attributed to the high market penetration of these tests in the global market. COVID-19 pandemic outbreak is projected to offer lucrative opportunities to key players for business expansion and innovative product offerings about glucose monitoring. Moreover, A1C testing also known as glycated hemoglobin testing is expected to witness significant growth in the market due to high convenience. This is a relatively simple blood test that shows the average blood sugar level, helping in the diagnosis of diabetes and monitoring of diabetes treatment. Additionally, the outbreak of the SARS-CoV-2 virus around the world has propelled the global market for blood testing. Several market players are currently engaged in or have developed a serology test/COVID-19 antibody test that uses a blood sample from the suspected individual.
Blood Testing Market, By Test Type
· Glucose · A1C · Direct LDL · Lipid panel · Prostate-specific antigen · COVID-19 · BUN testing · Vitamin D · Thyroid-stimulating hormone · Serum Nicotine / Cotinine · High sensitivity CRP · Testosterone · ALT · Cortisol · Creatinine · AST · Other tests
Blood Testing Market Regional Overview
In terms of region, North America commanded a major share of the global blood testing market. This can be mainly attributed to the availability of high-end diagnostic tools and favorable insurance policies in this region. Similarly, the market in the Asia Pacific is anticipated to witness the fastest CAGR over the forecast period. The growing prevalence of chronic diseases in developing countries such as India and China is a major factor boosting the growth of the market. In addition, several multinational companies are investing heavily in this region, which further supports the blood testing market’s expansion in this region.
Blood Testing Market, By Geography
· North America (US & Canada) · Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe) · Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific) · LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Blood Testing Market Competitor overview
Some key developments and strategies adopted by manufacturers in Blood Testing are highlighted below.
· In May 2020, DarioHealth Corp., a global digital therapeutics (DTx) innovator, announced that in an effort to reduce contact between healthcare providers and patients in hospital settings, limit COVID-19 exposure, and preserve personal protective equipment, the U.S. Food and Drug Administration (FDA) has recognized that home-use blood glucose meters including Dario's smartphone-connected metering device may be used by patients with diabetes who are hospitalized due to COVID-19 to check their own blood glucose levels and provide the readings to the health care personnel caring for them.
Blood Testing Market, Key Players
· F. Hoffmann-La Roche AG · Becton Dickinson and Company · Bruker Corporation · Siemens AG · Thermo Fisher Scientific, Inc · Abbott Diagnostics · Bio-Rad Laboratories Inc. · Roche Diagnostics · Quest Diagnostics · Danaher Corporation · Biomerica, Inc. · bioMérieux S.A. · Trinity Biotech PLC
Blood Testing Market Study Global Market Analysis, Insights and Forecast, 2020-2027
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1. Key Emerging Trends – For Major Countries
4.2. Latest Technological Advancement
4.3. Regulatory Landscape
4.4. Industry SWOT Analysis
4.5. Porters Five Forces Analysis
5. Global Blood Testing Market Analysis (USD Billion), Insights and Forecast, 2020-2027
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast – By Test Type
5.2.1. Glucose
5.2.2. A1C
5.2.3. Direct LDL
5.2.4. Lipid panel
5.2.5. Prostate-specific antigen
5.2.6. COVID-19
5.2.7. BUN testing
5.2.8. Vitamin D
5.2.9. Thyroid-stimulating hormone
5.2.10. Serum Nicotine / Cotinine
5.2.11. High sensitivity CRP
5.2.12. Testosterone
5.2.13. ALT
5.2.14. Cortisol
5.2.15. Creatinine
5.2.16. AST
5.2.17. Other tests
5.3. Market Analysis, Insights and Forecast – By Region
5.3.1. North America
5.3.2. Europe
5.3.3. Asia Pacific
5.3.4. Latin America, Middle East and Africa
6. North America Blood Testing Market Analysis (USD Billion), Insights and Forecast, 2020-2027
6.1. Key Findings / Summary
6.2. Market Analysis, Insights and Forecast – By Test Type
6.2.1. Glucose
6.2.2. A1C
6.2.3. Direct LDL
6.2.4. Lipid panel
6.2.5. Prostate-specific antigen
6.2.6. COVID-19
6.2.7. BUN testing
6.2.8. Vitamin D
6.2.9. Thyroid-stimulating hormone
6.2.10. Serum Nicotine / Cotinine
6.2.11. High sensitivity CRP
6.2.12. Testosterone
6.2.13. ALT
6.2.14. Cortisol
6.2.15. Creatinine
6.2.16. AST
6.2.17. Other tests
6.3. Market Analysis, Insights and Forecast – By Country
6.3.1. U.S.
6.3.2. Canada
7. Europe Blood Testing Market Analysis (USD Billion), Insights and Forecast, 2020-2027
7.1. Key Findings / Summary
7.2. Market Analysis, Insights and Forecast – By Test Type
7.2.1. Glucose
7.2.2. A1C
7.2.3. Direct LDL
7.2.4. Lipid panel
7.2.5. Prostate-specific antigen
7.2.6. COVID-19
7.2.7. BUN testing
7.2.8. Vitamin D
7.2.9. Thyroid-stimulating hormone
7.2.10. Serum Nicotine / Cotinine
7.2.11. High sensitivity CRP
7.2.12. Testosterone
7.2.13. ALT
7.2.14. Cortisol
7.2.15. Creatinine
7.2.16. AST
7.2.17. Other tests
7.3. Market Analysis, Insights and Forecast – By Country
7.3.1. UK
7.3.2. Germany
7.3.3. France
7.3.4. Italy
7.3.5. Spain
7.3.6. Russia
7.3.7. Rest of Europe
8. Asia Pacific Blood Testing Market Analysis (USD Billion), Insights and Forecast, 2020-2027
8.1. Key Findings / Summary
8.2. Market Analysis, Insights and Forecast – By Test Type
8.2.1. Glucose
8.2.2. A1C
8.2.3. Direct LDL
8.2.4. Lipid panel
8.2.5. Prostate-specific antigen
8.2.6. COVID-19
8.2.7. BUN testing
8.2.8. Vitamin D
8.2.9. Thyroid-stimulating hormone
8.2.10. Serum Nicotine / Cotinine
8.2.11. High sensitivity CRP
8.2.12. Testosterone
8.2.13. ALT
8.2.14. Cortisol
8.2.15. Creatinine
8.2.16. AST
8.2.17. Other tests
8.3. Market Analysis, Insights and Forecast – By Country
8.3.1. China
8.3.2. India
8.3.3. Japan
8.3.4. Australia
8.3.5. South East Asia
8.3.6. Rest of Asia Pacific
9. Latin America, Middle East and Africa Blood Testing Market Analysis (USD Billion), Insights and Forecast, 2020-2027
9.1. Key Findings / Summary
9.2. Market Analysis, Insights and Forecast – By Test Type
9.2.1. Glucose
9.2.2. A1C
9.2.3. Direct LDL
9.2.4. Lipid panel
9.2.5. Prostate-specific antigen
9.2.6. COVID-19
9.2.7. BUN testing
9.2.8. Vitamin D
9.2.9. Thyroid-stimulating hormone
9.2.10. Serum Nicotine / Cotinine
9.2.11. High sensitivity CRP
9.2.12. Testosterone
9.2.13. ALT
9.2.14. Cortisol
9.2.15. Creatinine
9.2.16. AST
9.2.17. Other tests
9.3. Market Analysis, Insights and Forecast – By Country
9.3.1. Brazil
9.3.2. Saudi Arabia
9.3.3. UAE
9.3.4. Rest of LAMEA
10. Competitive Analysis
10.1. Company Market Share Analysis, 2018
10.2. Key Industry Developments
10.3. Company Profile
10.4. F. Hoffmann-La Roche AG
10.4.1. Business Overview
10.4.2. Segment 1 & Service Offering
10.4.3. Overall Revenue
10.4.4. Geographic Presence
10.4.5. Recent Development
*Similar details will be provided for the following companies
10.5. Becton Dickinson and Company
10.6. Bruker Corporation
10.7. Siemens AG
10.8. Thermo Fisher Scientific, Inc
10.9. Abbott Diagnostics
10.10. Bio-Rad Laboratories Inc.
10.11. Roche Diagnostics
10.12. Quest Diagnostics
10.13. Danaher Corporation
10.14. Biomerica, Inc.
10.15. bioMérieux S.A.
List of Figures
Figure 1: Global Blood Testing Market Revenue Breakdown (USD Billion, %) by Region, 2019 & 2027
Figure 2: Global Blood Testing Market Value Share (%), By Segment 1, 2019 & 2027
Figure 3: Global Blood Testing Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 4: Global Blood Testing Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 5: Global Blood Testing Market Value Share (%), By Segment 2, 2019 & 2027
Figure 6: Global Blood Testing Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 7: Global Blood Testing Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 8: Global Blood Testing Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 9: Global Blood Testing Market Forecast (USD Billion), by Others, 2016-2027
Figure 10: Global Blood Testing Market Value Share (%), By Segment 3, 2019 & 2027
Figure 11: Global Blood Testing Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 12: Global Blood Testing Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 13: Global Blood Testing Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 14: Global Blood Testing Market Forecast (USD Billion), by Others, 2016-2027
Figure 15: Global Blood Testing Market Value (USD Billion), by Region, 2019 & 2027
Figure 16: North America Blood Testing Market Value Share (%), By Segment 1, 2019 & 2027
Figure 17: North America Blood Testing Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 18: North America Blood Testing Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 19: North America Blood Testing Market Value Share (%), By Segment 2, 2019 & 2027
Figure 20: North America Blood Testing Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 21: North America Blood Testing Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 22: North America Blood Testing Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 23: North America Blood Testing Market Forecast (USD Billion), by Others, 2016-2027
Figure 24: North America Blood Testing Market Value Share (%), By Segment 3, 2019 & 2027
Figure 25: North America Blood Testing Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 26: North America Blood Testing Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 27: North America Blood Testing Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 28: North America Blood Testing Market Forecast (USD Billion), by Others, 2016-2027
Figure 29: North America Blood Testing Market Forecast (USD Billion), by U.S., 2016-2027
Figure 30: North America Blood Testing Market Forecast (USD Billion), by Canada, 2016-2027
Figure 31: Latin America Blood Testing Market Value Share (%), By Segment 1, 2019 & 2027
Figure 32: Latin America Blood Testing Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 33: Latin America Blood Testing Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 34: Latin America Blood Testing Market Value Share (%), By Segment 2, 2019 & 2027
Figure 35: Latin America Blood Testing Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 36: Latin America Blood Testing Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 37: Latin America Blood Testing Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 38: Latin America Blood Testing Market Forecast (USD Billion), by Others, 2016-2027
Figure 39: Latin America Blood Testing Market Value Share (%), By Segment 3, 2019 & 2027
Figure 40: Latin America Blood Testing Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 41: Latin America Blood Testing Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 42: Latin America Blood Testing Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 43: Latin America Blood Testing Market Forecast (USD Billion), by Others, 2016-2027
Figure 44: Latin America Blood Testing Market Forecast (USD Billion), by Brazil, 2016-2027
Figure 45: Latin America Blood Testing Market Forecast (USD Billion), by Mexico, 2016-2027
Figure 46: Latin America Blood Testing Market Forecast (USD Billion), by Rest of Latin America, 2016-2027
Figure 47: Europe Blood Testing Market Value Share (%), By Segment 1, 2019 & 2027
Figure 48: Europe Blood Testing Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 49: Europe Blood Testing Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 50: Europe Blood Testing Market Value Share (%), By Segment 2, 2019 & 2027
Figure 51: Europe Blood Testing Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 52: Europe Blood Testing Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 53: Europe Blood Testing Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 54: Europe Blood Testing Market Forecast (USD Billion), by Others, 2016-2027
Figure 55: Europe Blood Testing Market Value Share (%), By Segment 3, 2019 & 2027
Figure 56: Europe Blood Testing Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 57: Europe Blood Testing Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 58: Europe Blood Testing Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 59: Europe Blood Testing Market Forecast (USD Billion), by Others, 2016-2027
Figure 60: Europe Blood Testing Market Forecast (USD Billion), by U.K., 2016-2027
Figure 61: Europe Blood Testing Market Forecast (USD Billion), by Germany, 2016-2027
Figure 62: Europe Blood Testing Market Forecast (USD Billion), by France, 2016-2027
Figure 63: Europe Blood Testing Market Forecast (USD Billion), by Italy, 2016-2027
Figure 64: Europe Blood Testing Market Forecast (USD Billion), by Spain, 2016-2027
Figure 65: Europe Blood Testing Market Forecast (USD Billion), by Russia, 2016-2027
Figure 66: Europe Blood Testing Market Forecast (USD Billion), by Rest of Europe, 2016-2027
Figure 67: Asia Pacific Blood Testing Market Value Share (%), By Segment 1, 2019 & 2027
Figure 68: Asia Pacific Blood Testing Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 69: Asia Pacific Blood Testing Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 70: Asia Pacific Blood Testing Market Value Share (%), By Segment 2, 2019 & 2027
Figure 71: Asia Pacific Blood Testing Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 72: Asia Pacific Blood Testing Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 73: Asia Pacific Blood Testing Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 74: Asia Pacific Blood Testing Market Forecast (USD Billion), by Others, 2016-2027
Figure 75: Asia Pacific Blood Testing Market Value Share (%), By Segment 3, 2019 & 2027
Figure 76: Asia Pacific Blood Testing Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 77: Asia Pacific Blood Testing Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 78: Asia Pacific Blood Testing Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 79: Asia Pacific Blood Testing Market Forecast (USD Billion), by Others, 2016-2027
Figure 80: Asia Pacific Blood Testing Market Forecast (USD Billion), by China, 2016-2027
Figure 81: Asia Pacific Blood Testing Market Forecast (USD Billion), by India, 2016-2027
Figure 82: Asia Pacific Blood Testing Market Forecast (USD Billion), by Japan, 2016-2027
Figure 83: Asia Pacific Blood Testing Market Forecast (USD Billion), by Australia, 2016-2027
Figure 84: Asia Pacific Blood Testing Market Forecast (USD Billion), by Southeast Asia, 2016-2027
Figure 85: Asia Pacific Blood Testing Market Forecast (USD Billion), by Rest of Asia Pacific, 2016-2027
Figure 86: Middle East & Africa Blood Testing Market Value Share (%), By Segment 1, 2019 & 2027
Figure 87: Middle East & Africa Blood Testing Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 88: Middle East & Africa Blood Testing Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 89: Middle East & Africa Blood Testing Market Value Share (%), By Segment 2, 2019 & 2027
Figure 90: Middle East & Africa Blood Testing Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 91: Middle East & Africa Blood Testing Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 92: Middle East & Africa Blood Testing Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 93: Middle East & Africa Blood Testing Market Forecast (USD Billion), by Others, 2016-2027
Figure 94: Middle East & Africa Blood Testing Market Value Share (%), By Segment 3, 2019 & 2027
Figure 95: Middle East & Africa Blood Testing Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 96: Middle East & Africa Blood Testing Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 97: Middle East & Africa Blood Testing Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 98: Middle East & Africa Blood Testing Market Forecast (USD Billion), by Others, 2016-2027
Figure 99: Middle East & Africa Blood Testing Market Forecast (USD Billion), by GCC, 2016-2027
Figure 100: Middle East & Africa Blood Testing Market Forecast (USD Billion), by South Africa, 2016-2027
Figure 101: Middle East & Africa Blood Testing Market Forecast (USD Billion), by Rest of Middle East & Africa, 2016-2027
List of Tables
Table 1: Global Blood Testing Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 2: Global Blood Testing Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 3: Global Blood Testing Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 4: Global Blood Testing Market Revenue (USD Billion) Forecast, by Region, 2016-2027
Table 5: North America Blood Testing Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 6: North America Blood Testing Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 7: North America Blood Testing Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 8: North America Blood Testing Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 9: Europe Blood Testing Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 10: Europe Blood Testing Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 11: Europe Blood Testing Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 12: Europe Blood Testing Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 13: Latin America Blood Testing Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 14: Latin America Blood Testing Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 15: Latin America Blood Testing Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 16: Latin America Blood Testing Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 17: Asia Pacific Blood Testing Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 18: Asia Pacific Blood Testing Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 19: Asia Pacific Blood Testing Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 20: Asia Pacific Blood Testing Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 21: Middle East & Africa Blood Testing Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 22: Middle East & Africa Blood Testing Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 23: Middle East & Africa Blood Testing Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 24: Middle East & Africa Blood Testing Market Revenue (USD Billion) Forecast, by Country, 2016-2027